Severe acneiform rash | Initial management | Outcome | Dose modification |
First occurrence | Delay infusion 1 to 2 weeks | Improvement | Continue at 250 mg/m2 |
No improvement | Discontinue cetuximab | ||
Second occurrence | Delay infusion 1 to 2 weeks | Improvement | Reduce dose to 200 mg/m2 |
No improvement | Discontinue cetuximab | ||
Third occurrence | Delay infusion 1 to 2 weeks | Improvement | Reduce dose to 150 mg/m2 |
No improvement | Discontinue cetuximab | ||
Fourth occurrence | Discontinue cetuximab |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟